Effects of CoSeal on Bleeding & Adhesions in Pediatric Heart Surgery
- Conditions
- Surgery-Induced Tissue AdhesionsHemorrhageCongenital Heart Defect
- Interventions
- Device: CoSeal Surgical Spray Group
- Registration Number
- NCT01330433
- Lead Sponsor
- Loma Linda University
- Brief Summary
This is a prospective, randomized, open-label, blinded-evaluator study that will evaluate the effectiveness of a surgical sealant (CoSeal) composed of biocompatible polyethylene glycol on the formation of mediastinal and pericardial adhesions in children undergoing staged surgical reconstruction (potential procedures include: Blalock-Taussig Type Operation, Classical Glenn Procedure, Bidirectional Glenn Procedure, Norwood). Additionally, bleeding will be evaluated by drainage post-operatively through surgical site drainage output.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
- Have an acceptable surrogate capable of giving consent on the subject's behalf.
- Pediatric patients ages 0 - 17
- Have a cardiac disease which requires staged cardiac surgery and resternotomy
- Non-emergent state or emergent state with sufficient time to educate and consent
- An immune system disorder
- Unplanned reoperation
- Known hypersensitivity to components in CoSeal
- Patients undergoing reoperation less than 3 months after the primary surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description CoSeal Spray Group CoSeal Surgical Spray Group CoSeal Spray will be applied at the end of the first staged procedure in patients randomized to the experimental group.
- Primary Outcome Measures
Name Time Method Severity of Adhesions at the Retrosternal Site Severity of adhesions data will be collected during approximately the first 30-60 minutes of the second staged surgery Severity of adhesions at seven predefined sites (pericardial or retrosternal, inferior or diaphragmatic region, right lateral or arterial region, region around great vessels). Severity of adhesions is graded as 0 = no adhesions, 1 = filmy and avascular, 2 = requiring blunt dissection, 3 = requiring sharp dissection, 4 = requiring extensive sharp dissection. Adhesion scores for each patient will be derived from the sum of adhesion severity scores at each site, from 0 (no adhesions) to 28 (cohesive adhesions at all sites).
Severity of Adhesions at the Diaphragm Site Severity of adhesions data will be collected during approximately the first 30-60 minutes of the second staged surgery Severity of adhesions at five predefined sites (retrosternal, diaphragmatic region, right lateral, left lateral, arterial base). Severity of adhesions is graded as 0 = no adhesions, 1 = filmy and avascular, 2 = requiring blunt dissection, 3 = requiring sharp dissection, 4 = requiring extensive sharp dissection. Adhesion scores for each patient will be derived from the sum of adhesion severity scores at each site, from 0 (no adhesions) to 28 (cohesive adhesions at all sites).
Post-operative Bleeding Post-operative bleeding data will be collected on average, during the first 36 hours after the surgery Post-operative bleeding through surgical site drainage output.
Adhesion Burden Time it takes for patient to be put on bypass (an average time between 0 and 120 minutes) Skin to bypass time as an indicator of adhesion burden.
Severity of Adhesions at the Arterial Base Site. Severity of adhesions data will be collected during approximately the first 30-60 minutes of the second staged surgery Severity of adhesions at five predefined sites (retrosternal, diaphragmatic region, right lateral, left lateral, arterial base). Severity of adhesions is graded as 0 = no adhesions, 1 = filmy and avascular, 2 = requiring blunt dissection, 3 = requiring sharp dissection, 4 = requiring extensive sharp dissection. Adhesion scores for each patient will be derived from the sum of adhesion severity scores at each site, from 0 (no adhesions) to 28 (cohesive adhesions at all sites).
Severity of Adhesions at the Left Lateral Site Severity of adhesions data will be collected during approximately the first 30-60 minutes of the second staged surgery Severity of adhesions at five predefined sites (retrosternal, diaphragmatic region, right lateral, left lateral, arterial base). Severity of adhesions is graded as 0 = no adhesions, 1 = filmy and avascular, 2 = requiring blunt dissection, 3 = requiring sharp dissection, 4 = requiring extensive sharp dissection. Adhesion scores for each patient will be derived from the sum of adhesion severity scores at each site, from 0 (no adhesions) to 28 (cohesive adhesions at all sites).
Severity of Adhesions at the Right Lateral Site Severity of adhesions data will be collected during approximately the first 30-60 minutes of the second staged surgery Severity of adhesions at five predefined sites (retrosternal, diaphragmatic region, right lateral, left lateral, arterial base). Severity of adhesions is graded as 0 = no adhesions, 1 = filmy and avascular, 2 = requiring blunt dissection, 3 = requiring sharp dissection, 4 = requiring extensive sharp dissection. Adhesion scores for each patient will be derived from the sum of adhesion severity scores at each site, from 0 (no adhesions) to 28 (cohesive adhesions at all sites).
- Secondary Outcome Measures
Name Time Method Hospital Stay Length of stay after second surgery up to 1 month Number of days post surgery.
Trial Locations
- Locations (1)
Loma Linda University Medical Center
🇺🇸Loma Linda, California, United States